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Short Conceptual Overview
Roger Schneiter* and Antonio Di Pietro*
The CAP protein superfamily: function in sterol 
export and fungal virulence
Abstract: CAP superfamily proteins, also known as sperm-
coating proteins, are found in all kingdoms of life and have 
been implicated in a variety of physiological contexts, 
including immune defense in plants and mammals, sperm 
maturation and fertilization, fungal virulence, and toxicity 
of insect and reptile venoms as well as prostate and brain 
cancer. CAP family members are mostly secreted glycopro-
teins that are highly stable in the extracellular fluid. All 
members of the superfamily share a common CAP domain 
of approximately 150 amino acids, which adopts a unique 
α-β-α sandwich fold. The conserved structure suggests that 
CAP proteins exert fundamentally similar functions. How-
ever, the molecular mode of action of this protein family 
has remained enigmatic. The budding yeast Saccharomy-
ces cerevisiae has three CAP family members designated 
Pry (pathogen related in yeast), and recent evidence indi-
cates that they act as sterol-binding and export proteins. 
Expression of the mammalian CAP protein CRISP2, which 
binds sterols in vitro, complements the sterol export defect 
of a yeast pry mutant, suggesting that sterol binding and 
export is conserved among different CAP family members. 
Collectively, these observations suggest that CAP family 
members constitute a novel class of secreted extracellular 
sterol-binding proteins. A ligand-binding activity of the 
CAP domain could explain many of the biological activities 
attributed to these proteins. For example, the strong induc-
tion of plant pathogenesis-related 1 protein upon exposure 
to pathogens may serve to inhibit pathogen proliferation 
by extracting sterols from the pathogen membrane. Simi-
larly, the presence of these proteins in the venom of toxic 
insects and reptiles or in the secretome of pathogenic fungi 
might inflict damage by sequestering sterols or related 
small hydrophobic compounds from the host tissue.
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Introduction
The CAP protein superfamily (pfam PF00188) was named 
after the three founding members cysteine-rich secre-
tory protein, antigen 5, and pathogenesis-related 1, and 
comprises more than 4500 known members in over 1500 
species from all kingdoms of life. CAP proteins have been 
implicated in a wide variety of biological processes, 
including immune defense in mammals and plants, 
pathogen virulence, sperm maturation and fertilization, 
venom toxicity, and prostate and brain cancer. Almost 
all CAP proteins are secreted glycoproteins that exhibit a 
high stability in the extracellular fluid over a wide range 
of environmental conditions. The overall structural con-
servation within the CAP superfamily is likely to result in 
fundamentally similar functions for the CAP domains in 
the different members, whereas the diversity outside of 
this core region may alter target specificity and thus mod-
ulate physiological responses. For example, mammalian 
CAP proteins have been classified into nine subfamilies 
that differ in regions flanking the conserved CAP domain 
(1). CAP proteins are an intensely studied class of proteins; 
however, their mode of action has remained elusive [for 
reviews, see (1, 2)].
The first founding member of the CAP superfamily is 
the plant pathogenesis-related protein-1 (PR-1), which was 
identified in 1970 among the proteins induced in tobacco 
leaves upon viral infection (3). Plant pathogenesis-related 
(PR) proteins are classified into 17 families according to 
their molecular mass, PR-1 being the smallest one with 
14 kDa. Subsequent studies revealed that other PR pro-
teins, such as glucanase (PR-2), chitinase (PR-3, 4, 8, 11), 
protease inhibitor (PR-6), peroxidase (PR-9), or ribonu-
clease activity (PR-10), have different biochemical activi-
ties, serving as a direct line of defense against fungal and 
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bacterial pathogens (4, 5). Intriguingly, even though it 
is the most abundant PR protein, PR-1 remains the only 
member for which no biochemical function is known. 
Some PR-1 proteins display antimicrobial activity against 
fungal and oomycete pathogens, but their mechanism of 
action is unclear (6, 7).
Antigen 5 (Ag5) is the second founding member of 
the CAP superfamily, an abundant protein present in 
the venom-secretory ducts of stinging insects that elicits 
a strong allergenic response. Ag5 proteins form part of a 
cocktail of salivary proteins that are believed to function 
either in suppression of the host immune system or in 
prevention of blood clotting to prolong feeding (8). The 
biochemical activity of Ag5 is unknown, but a related 
CAP protein from hookworm, neutrophil inhibitory factor 
(NIF), was shown to abrogate the adhesion of neutrophils 
to endothelial cells by binding to and thereby blocking 
integrin action (9).
Cysteine-rich secretory proteins (CRISPs) constitute 
the third founding members of the CAP superfamily. 
They are highly enriched in the mammalian reproductive 
tract and in the venom-secretory ducts of snakes, lizards, 
and other vertebrates. CRISPs are two-domain proteins 
containing an N-terminal CAP domain and a C-terminal 
cysteine-rich domain (CRD) with a conserved spacing of 
up to 16 Cys residues. This modular structure is likely to 
result in a dual-function protein with distinct activities 
associated with the N-terminal CAP domain and the C-ter-
minal CRD domain (1, 10). Recent data suggest that the 
CRD adopts a fold similar to potassium channel inhibitors 
and may thus modulate the activity of cyclic nucleotide-
gated ion channels (see the following) (11).
Structure of CAP proteins
CAP proteins share only limited sequence identity, includ-
ing two signature PROSITE-recognized motifs referred to 
as CRISP motifs (http://expasy.ch/prosite) (Figure 1A). The 
NMR structure of plant PR-1 protein and the crystal struc-
tures of several CAP proteins revealed that the conserved 
CAP sequence motifs are present in a small and structur-
ally conserved 17- to 21-kDa CAP domain, which adopts 
a unique α-β-α sandwich fold. The tight packing of the 
α-helices on both sides of the central β-sheet results in a 
compact, bipartite molecular core, which is stabilized by 
hydrophobic interactions, multiple hydrogen bonds, and 
two highly conserved disulfide bonds (Figure 1B). These 
features are thought to provide the high thermal, pH, and 
proteolytic stability reported for CAP proteins, consistent 
with the structural requirements of an extracellular func-
tion (11–14).
A seminal study used the NMR structure of plant PR-1 
as template to model the structure of the human glioma 
pathogenesis-related protein 1 (GLIPR1), revealing the 
presence of four conserved partially surface exposed 
residues, two histidines, and two glutamic acids. The 
high structural conservation of the CAP domain immedi-
ately suggested a common mode of action of these pro-
teins in plant pathogen defense and brain immune cells 
(13). These surface residues were later suggested to form 
part of a putative active-site triad of a CAP protein with 
a reported in vitro protease activity, Tex31 (15). However, 
although a large number of proteins within the superfam-
ily contain a CAP domain in isolation (e.g., Ag5 and PR-1), 
many others contain additional N- or C-terminal exten-
sions (1).
Proposed functions of CAP proteins
A 28-kDa CAP family member, Tex 31, was purified from 
the venom duct of the marine cone snail Conus textile 
and found to have proteolytic activity in vitro. This activ-
ity was abolished by serine protease inhibitors and 
stimulated by addition of Ca2+ (15). Modeling of the Tex31 
sequence to the structure of PR-1 and Ag5 was consistent 
with a possible catalytic role of the conserved surface-
exposed histidine and glutamic acid residues (15). The 
lack of a conserved serine in this putative active-site triad 
led others to propose that dimerization of CAP proteins 
is required to complete the formation of the active site 
(14). However, subsequent studies failed to detect pro-
tease activity with purified CAP family members, and a 
conclusive demonstration of the protease activity for a 
mammalian, fungal, or plant CAP protein is still lacking 
(11, 16, 17). Apart from a possible catalytic activity, the 
CAP domain has been suggested to form a stable scaf-
fold for biological interactions with other proteins (18), 
although no interactions of plant PR-1 with other proteins 
have been detected (19).
CRISP subfamily CAP proteins harboring a C-termi-
nal CRD have been associated with modulation of the 
activity of ion channels, which might account for their 
role in sperm maturation and venom toxicity (11, 20, 21). 
However, whether the CRD acts directly on the ion channel 
or whether CRISP proteins affect the channel activity indi-
rectly, for example, through concomitant alterations of 
the lipid composition of the plasma membrane, remains 
to be established.
R. Schneiter and A. Di Pietro: Virulence and ligand-binding activity of CAP proteins      521
The role of CAP proteins in humans 
and their implication in cancer
Transcriptional deregulation of two CAP superfamily 
members in malignant cells suggested a possible function 
of these proteins in cancer development or progression. 
GLIPR1 and GLIPR2 (also known as RTVP1/GAPR1) are 
among the most highly up-regulated transcripts in human 
gliomas, i.e., astrocyte-derived brain tumors, which 
account for over 65% of all human primary brain tumors 
(22). Interestingly, GLIPR1 has pro-apoptotic activity and 
acts as a tumor suppressor in prostate cancer (23). On the 
other hand, the CRISP family member CRISP3 is expressed 
in different cell types of the immune system including 
pre-B cells, and is believed to function in innate immu-
nity. Transcription of CRISP3 is dramatically increased in 
prostate cancer and serves as a potential biomarker (24). 
These observations raise the possibility that CAPs may 
be used as diagnostic agents and perhaps, ultimately, as 
therapeutic targets (1).
Yeast Pry proteins function in sterol 
binding and export
New insight into the function of the CAP family of pro-
teins comes from recent studies in budding yeast. The 
S. cerevisiae genome codes for three members of this 
A
B
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Figure 1 Conservation and structure of the CAP domain. 
(A) Partial sequence alignment of a core set of CAP proteins, PR-1 (Arabidopsis thaliana), CRISP2 (Homo sapiens), Pry1 (S. cerevisiae), 
Fpr1 (F. oxysporum). Secondary-structure elements are indicated and conserved residues of a putative active site are in blue; conserved 
cysteines are in red. The two CRISP motifs are shaded. (B) Ribbon drawing of the CAP domain of PR-1. α-Helices are shown in red, β-strands 
in cyan. Amino acid side chains that form a large hydrophobic cluster are shown in yellow; those forming a smaller hydrophobic cluster 
are green. Disulfide bonds are shown as ball-and-stick models. (C) Space-filling representation of PR-1 with the partially surface exposed 
histidinyl and glutamyl residues depicted in blue and red, respectively. (B) and (C) are adapted from (13) (© 1998, National Academy of  
Sciences, USA).
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protein superfamily, termed Pry. Pry1 and Pry2 are 
secreted glycoproteins, whereas Pry3 is associated with 
the cell wall and contains a signal for attachment of a 
glycosylphosphatidylinositol anchor (25, 26). Pry1 and 
Pry2 share a redundant function in the export of acety-
lated cholesterol, a lipid intermediate that accumulates 
in cells lacking a corresponding lipid deacetylase (27). 
Double mutants lacking both Pry1 and Pry2 accumulate 
cholesteryl acetate in the endoplastic reticulum mem-
brane, whereas in the presence of a wild- type copy of 
either Pry1 or Pry2 cholesteryl acetate is secreted from 
the cells and accumulates in the culture media (26, 27). 
Purified Pry1 and Pry2 bind both free cholesterol and 
cholesteryl acetate in a dose-dependent manner, con-
sistent with a role of Pry proteins in binding and solu-
bilizing sterols and possibly other small hydrophobic 
compounds.
Importantly, the sterol binding and export function of 
the yeast CAP proteins Pry1 is confined to the CAP domain 
because expression of the CAP domain alone is sufficient 
to rescue the sterol export phenotype of a pry1Δ pry2Δ 
double mutant, and the CAP domain of Pry1 alone binds 
sterols in vitro. Evidence for the specificity of the protein-
lipid interaction comes from the finding that it is pre-
vented by mutation of a highly conserved cysteine residue 
known to form a disulfide bridge. Most importantly, the 
lipid-binding and export function of the Pry proteins 
appears to be conserved among the members of the CAP 
protein superfamily because expression of the human 
CAP protein CRISP2 relieves the lipid export block of a 
yeast pry1Δ pry2Δ double mutant, and purified CRISP2 
binds sterols in vitro (26).
Cells lacking PRY1 and PRY2 are hypersensitive to 
the plant oil eugenol, and this phenotype is also rescued 
by expression of human CRISP2. Eugenol is a member 
of the allylbenzene class of compounds present in clove 
oil, nutmeg, cinnamon, and bay leaf that is used as local 
antiseptic and anesthetic and has antifungal and bac-
teriostatic activity (28). Pry proteins bind eugenol and 
confer dose-dependent resistance against this potential 
membrane-perturbing compound (26, 27). Thus, members 
of the CAP protein superfamily may exert a wide variety 
of physiological functions through binding to lipids and 
related small hydrophobic compounds that affect the 
integrity of cellular membranes.
In the light of these results, it is conceivable that 
the function of plant PR-1 proteins in pathogen defense 
involves a sterol binding and sequestration mechanism. 
Capturing sterols from the surface membrane of patho-
gens could exert a growth inhibitory effect or even kill the 
invaders. Sterols are not only an essential lipid constituent 
in eukaryotic plasma membranes, but also bacteria syn-
thesize hopanoid and tetrahymenol compounds that are 
structurally and functionally related to sterols (29–31). 
Drugs that target ergosterol, the fungus-specific mem-
brane sterol, or products like azoles that inhibit specific 
steps in ergosterol biosynthesis, are widely used in anti-
fungal treatments of plants, animals, and humans (32). 
The sterol-binding mechanism of CAP proteins could 
therefore be exploited as a novel mode of action to target 
invasive microbial infections.
CAP proteins act as fungal virulence 
determinants
CAP proteins have recently emerged as novel virulence 
factors in pathogenic fungi. The RBT4 gene encodes a 
predicted secreted CAP protein from the human patho-
gen Candida albicans that was originally identified in a 
search for transcripts under control of a morphogenetic 
regulator, Tup1. Candida mutants lacking RBT4 had 
reduced virulence both in a rabbit cornea and in a sys-
temic mouse infection model (33). Rbt4, together with a 
close homolog, Rbe1, were recently detected in the fungal 
secretome and shown to be part of a family of five CaPRY 
proteins in C. albicans. Whereas single deletions of RBE1 
or RBT4 resulted in a moderate attenuation in a mouse 
model for disseminated candidiasis, the rbe1Δ rbt4Δ 
double mutant was dramatically reduced, suggesting that 
different CAP family proteins have partially redundant 
roles in virulence (34).
Another CAP family protein, Fpr1, was reported 
in the ascomycete Fusarium oxysporum, a ubiquitous 
fungal pathogen that causes vascular wilt disease on a 
wide range of plant species and can produce life-threat-
ening infections in immunocompromised humans (17). 
Fpr1 is an extracellular protein with an N-terminal secre-
tion signal, a serine/proline-rich region of unknown 
function, and a C-terminal CAP domain including the 
highly conserved His and Glu residues. Western blot 
analysis of culture supernatants revealed that Fpr1 is 
secreted by F. oxysporum as a precursor migrating at 
40  kDa and rapidly converted by proteolytic cleavage 
into the major 30-kDa form. Strikingly, transcription 
of the fpr1 gene was rapidly induced during growth in 
human blood, and immunodepressed mice infected 
with fpr1Δ mutants exhibited significantly lower mor-
tality rates than those infected with the wild-type strain. 
Importantly, the CAP domain was required for the func-
tion of Fpr1 in virulence because complementation with 
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a native fpr1 allele restored virulence of the fpr1Δ mutant 
to wild-type levels, whereas an allele in which two of 
the predicted active-site residues had been mutated 
(fpr1H170A,E177A) did not (17).
Evidence for expansion of CAP 
proteins in fungal pathogens
A survey of predicted CAP proteins in sequenced fungal 
genomes revealed that most fungi contain two members 
of the protein family that cluster into well-separated 
clades. The presence of these ‘core’ CAP proteins in non-
pathogens including yeast, suggests they must fulfill 
functions unrelated to pathogenicity, such as binding 
and export of sterols and related small hydrophobic com-
pounds (26). However, some fungal pathogens display a 
remarkable increase in the number of CAP family pro-
teins. C. albicans has five members, all of which cluster 
within a separate Hemiascomycete-specific clade, sug-
gesting that this CAP gene family has expanded recently 
during evolution. Even more strikingly, the plant patho-
gens F. oxysporum, Fusarium graminearum, and Magna-
porthe grisea contain a new family of CAP proteins that 
appears phylogenetically closer to plant PR-1 proteins 
than to the fungus-specific clades, raising the intrigu-
ing possibility that their ancestor might have originated 
from a horizontal gene transfer event. Interestingly, 
the new clade also includes the F. oxysporum virulence 
determinant Fpr1 (17). Similarly, the genome of Monili-
ophthora perniciosa, a basidiomycete fungus that causes 
witches’ broom disease in cacao, was shown to contain 
11 CAP family genes some of which were highly and spe-
cifically expressed during the interaction with the host 
plant (35). Collectively, these findings suggest a possible 
link between the evolutionary expansion of fungal CAP 
proteins and pathogenicity.
Possible function of CAP proteins 
during fungal infection
Although the role of CAP proteins in fungal virulence 
remains unclear, the capacity of the yeast homologs to 
bind sterols and related small hydrophobic compounds 
suggests a parallel between the ligand-binding activity 
and their function during infection. This question is of 
particular interest because some CAP proteins from the 
pathogen-specific clades lack several of the conserved 
cysteine residues involved in intramolecular disulfide 
bridges, suggesting distinct ligand-binding properties 
and/or protein stabilities (17).
Fungal infections, particularly in humans, are diffi-
cult to control because, as eukaryotes, their metabolism 
closely resembles ours. As a result, most current fungi-
cides and medical antifungals are based on only a handful 
of active principles. Sterol metabolism is a known Achil-
les heel of fungi and acts as a major fungicide target in 
medicine and agriculture (36). Intriguingly, plants have 
exploited ergosterol binding in the fungal membrane as a 
mechanism of antifungal phytoalexins such as the tomato 
glycoalkaloid tomatine (37). The finding that secreted CAP 
proteins are conserved fungal virulence factors suggests 
that they could serve as potential targets to reduce fungal 
infection.
Outlook
The breakthrough finding that the yeast CAP family 
members Pry1 and Pry2 are required for exporting cho-
lesteryl acetate and that these proteins directly bind the 
lipid has provided a new lead to address the molecular 
function of CAP family members in other organisms. It is 
conceivable that CAP proteins exert their multitude of bio-
logical tasks through a common mechanism of binding/
sequestering sterols and/or related small hydrophobic 
compounds. Thus, sterol sequestration from the host 
tissue by fungal pathogens might facilitate tissue penetra-
tion, consistent with the role of CAP proteins in virulence. 
Meanwhile, targeting of sterols from microbial invaders 
by host CAP proteins could account for their function in 
innate immunity of plants and mammals. Finally, inter-
action with lipids might also contribute to the multi-
ple roles of human CAP proteins associated with cancer 
development.
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